https://doi.org/10.1186/s12933-019-0977-z
Y
Yosuke Okada
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
375
Papers
7.7K
Citations
46
h-index
153
i10-index
Yosuke Okada is an academic researcher from Jichi Medical University. The author has contributed to research in topics: Diabetes Treatment and Management & Diabetes Management and Research & Bone health and treatments. The author has an h-index of 46, co-authored 319 publications.
ORCID: 0000-0003-4998-9078Papers by this author
worksEfficacy of dapagliflozin versus sitagliptin on cardiometabolic risk factors in Japanese patients with type 2 diabetes: a prospective, randomized study (DIVERSITY-CVR)
2020 · Cardiovascular Diabetology · 112 citations
Effect of tofogliflozin on arterial stiffness in patients with type 2 diabetes: prespecified sub-analysis of the prospective, randomized, open-label, parallel-group comparative UTOPIA trial
2021 · Cardiovascular Diabetology · 55 citations
https://doi.org/10.1186/s12933-020-01206-1
Rationale and design of a multicenter placebo-controlled double-blind randomized trial to evaluate the effect of empagliflozin on endothelial function: the EMBLEM trial
2017 · Cardiovascular Diabetology · 31 citations
https://doi.org/10.1186/s12933-017-0532-8
The 2023 Guidelines for the management and treatment of glucocorticoid-induced osteoporosis
2024 · Journal of Bone and Mineral Metabolism · 29 citations
https://doi.org/10.1007/s00774-024-01502-w
The Influence of Tofogliflozin on Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus
2021 · Diabetes Therapy · 23 citations
https://doi.org/10.1007/s13300-021-01125-8
The Influence of Tofogliflozin on Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus
2021 · Diabetes Therapy · 23 citations
https://doi.org/10.1007/s13300-021-01125-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat